← Leaderboards
Edward Abraham
University Of Colorado Denver
$8,831,231
Attributed
$8,831,231
Total exposure
18
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–10$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$13,178,276 · 19
By mechanism
P01$5,858,437 · 3
R01$5,231,165 · 3
P50$1,376,670 · 1
N01$577,417 · 1
M01$134,587 · 11
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Sachin Wani$2,810,778
- James D Crapo$109,862,307
- Anirban Banerjee$10,607,479
- Michael J Pagliassotti$4,309,018
- Mark W Geraci$20,364,365
Others in their field
Top investigators on “Neutrophil”
- Charles Nicholas Serhan · Brigham And Women'S Hospital$23,875,763
- Hongbo R Luo · Children'S Hospital Boston$23,323,359
- Tanya N. Mayadas · Brigham And Women'S Hospital$21,795,639
- Victor Nizet · University Of California, San Diego$21,031,691
- J. Edwin Blalock · University Of Alabama At Birmingham$19,196,735
- Robert Fairchild · Cleveland Clinic Lerner Com-Cwru$18,658,323
Research focus
NeutrophilLung Injury, AcuteLungLung InjuryResearch StudyAdult Respiratory Distress SyndromeResearch PersonnelEndotoxinsCytokineHuman SubjectNeutrophil ActivationAffectAcuteSepsisConditionTlr2 GeneTlr4 GeneLaboratory MouseInflammationPathway InteractionsSignal TransductionHemorrhageInsightPlay
Grant awards (43)
Urokinase, Neutrophil Activation and Acute Lung Injury.$379,937
R01 · FY2010 · HL · contact PI
HMGB1 and neutrophil efferocytosis.$300,948
R01 · FY2010 · GM · contact PI
Neutrophil Activation in Acute Lung Injury$353,201
R01 · FY2009 · HL · contact PI
HMGBP1 in Shock$334,187
P50 · FY2009 · GM · contact PI
HMGB1 and neutrophil efferocytosis.$303,642
R01 · FY2009 · GM · contact PI
Neutrophil Activation in Acute Lung Injury$353,201
R01 · FY2008 · HL · contact PI
HMGBP1 in Shock$325,538
P50 · FY2008 · GM · contact PI
Urokinase, Neutrophil Activation and Acute Lung Injury$323,329
R01 · FY2008 · HL · contact PI
GENOMIC INFLUNENCES ON IMMUNOLOGIC RESPONSES TO PULMONARY ADMIN OF ENDOTOXIN$1,266
M01 · FY2008 · RR · contact PI
GENOMIC INFLUENCES ON ACUTE LUNG INJURY$435
M01 · FY2008 · RR · contact PI
HMGBP1 in Shock$365,976
P50 · FY2007 · GM · contact PI
Neutrophil Activation in Acute Lung Injury$353,201
R01 · FY2007 · HL · contact PI
Urokinase, Neutrophil Activation and Acute Lung Injury$327,644
R01 · FY2007 · HL · contact PI
GENOMIC INFLUNENCES ON IMMUNOLOGIC RESPONSES TO PULMONARY ADMIN OF ENDOTOXIN$10,772
M01 · FY2007 · RR · contact PI
GENOMIC INFLUENCES ON ACUTE LUNG INJURY$3,703
M01 · FY2007 · RR · contact PI
Neutrophil Activation in Acute Lung Injury$363,750
R01 · FY2006 · HL · contact PI
Urokinase, Neutrophil Activation and Acute Lung Injury$350,759
R01 · FY2006 · HL · contact PI
Clinical Core$266,128
P01 · FY2006 · HL · contact PI
PI3-K and Akt in Acute Lung Injury$266,128
P01 · FY2006 · HL · contact PI
HMGBP1 in Shock$178,078
P50 · FY2006 · GM · contact PI
GENOMIC INFLUENCES ON ACUTE LUNG INJURY$15,781
M01 · FY2006 · RR · contact PI
GENOMIC INFLUNENCES ON IMMUNOLOGIC RESPONSES TO PULMONARY ADMIN OF ENDOTOXIN$14,234
M01 · FY2006 · RR · contact PI
IMMUNOLOGIC RESPONSES TO PULMONARY ADMINISTRATION OF ENDOTOXIN-PHASE B$10,211
M01 · FY2006 · RR · contact PI
IMMUNOLOGIC RESPONSES TO PULMONARY ADMINISTRATION OF ENDOTOXIN-PHASE A$2,785
M01 · FY2006 · RR · contact PI
Urokinase, Neutrophil Activation and Acute Lung Injury$371,500
R01 · FY2005 · HL
PI3-K and Akt in Acute Lung Injury$252,187
P01 · FY2005 · HL
Clinical Core$252,187
P01 · FY2005 · HL
HMGBP1 in Shock$172,891
P50 · FY2005 · GM
IMMUNOLOGIC RESPONSES TO PULMONARY ADMINISTRATION OF ENDOTOXIN-PHASE A$23,161
M01 · FY2005 · RR
IMMUNOLOGIC RESPONSES TO PULMONARY ADMINISTRATION OF ENDOTOXIN-PHASE B$5,433
M01 · FY2005 · RR
Heterogeneous Neutrophil Responses in Acute Lung Injury$1,471,235
P01 · FY2004 · HL
NEUTROPHIL ACTIVATION IN ACUTE LUNG INJURY$289,291
R01 · FY2004 · HL
Effects of Drotrecogin Alfa on Immunologic Response$27,206
M01 · FY2004 · RR
Immunologic Responses to Pulmonary Administration$19,600
M01 · FY2004 · RR
Heterogeneous Neutrophil Responses in Acute Lung Injury$1,451,519
P01 · FY2003 · HL
NEUTROPHIL ACTIVATION IN ACUTE LUNG INJURY$289,662
R01 · FY2003 · HL
Heterogeneous Neutrophil Responses in Acute Lung Injury$1,424,291
P01 · FY2002 · HL
NEUTROPHIL ACTIVATION IN ACUTE LUNG INJURY$290,021
R01 · FY2002 · HL
Clinical Core$237,381
P01 · FY2002 · HL
PI3-K and Akt in Acute Lung Injury$237,381
P01 · FY2002 · HL
NEUTROPHIL ACTIVATION IN ACUTE LUNG INJURY$290,370
R01 · FY2001 · HL
CLINICAL CENTERS--A NETWORK FOR THE TREATMENT OF ARD$577,417
N01 · FY2000 · HR
NEUTROPHIL ACTIVATION IN ACUTE LUNG INJURY$290,709
R01 · FY2000 · HL